I attended and my opinion was nothing new other than reiterating the timeline for AMP945 application for idiopathic pulmonary fibrosis + pancreatic cancer regarding trials and data collection etc. Majority was spent voting on agenda items. There was no set time provided at the end for asking questions which i found odd. Not sure if this is normal now we are using zoom. Dr Lambert read off a a script most of the time. Market seems to have reacted well though.
I attended and my opinion was nothing new other than reiterating...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.001(1.64%) |
Mkt cap ! $11.83M | |||
| Open | High | Low | Value | Volume |
| 6.1¢ | 6.3¢ | 6.1¢ | $478 | 7.818K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 453551 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 135134 | 1 |
View Market Depth
| Last trade - 12.44pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
0.001 ( 1.64 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.0¢ | 6.0¢ | 15000 | ||
| Last updated 11.41am 30/04/2024 ? | |||||
| ATX (ASX) Chart |